SOUTH SAN FRANCISCO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) announced today that the company will host and webcast an analyst and investor briefing on November 12, 2012, in Boston, MA at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) or "The Liver Meeting®". The Hyperion Therapeutics analyst and investor briefing will take place from 6:30 p.m. – 7:30 p.m. Monday, November 12, 2012, in the Commonwealth Room of the Sheraton Hotel, connected to the Boston Hynes Convention Center.
